Physician profile
Michael D Marcus
NPI 1588622773
$6,065.10
in general payments reported to CMS, 2019-2025
44 companies · $1,090 in 2025
The $1,090 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $931 · 2020: $131 · 2021: $458 · 2022: $861 · 2023: $1,472 · 2024: $1,122 · 2025: $1,090.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,684.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $533.48 | 2021-2025 | Provenge |
| Pfizer INC. | $454.83 | 2019-2025 | |
| Procept Biorobotics Corporation | $371.75 | 2024-2025 | Aquabeam System |
| Boston Scientific Corporation | $345.35 | 2019-2022 | |
| Urogen Pharma, INC. | $339.38 | 2024-2025 | |
| Accord Healthcare, INC. | $332.28 | 2023-2025 | |
| Janssen Biotech, INC. | $320.69 | 2019-2025 | Rybrevant, Carvykti |
| Progenics Pharmaceuticals, INC. | $312.93 | 2022-2025 | Pylarify |
| Astellas Pharma US INC | $302.62 | 2019-2025 | Xtandi |
| Myriad Genetic Laboratories, INC. | $288.28 | 2021-2023 | Prolaris |
| Teleflex LLC | $174.30 | 2022-2024 | Urolift |
| Blue Earth Diagnostics | $173.31 | 2019-2025 | Posluma |
| Urovant Sciences INC | $156.09 | 2021-2022 | |
| Olympus America INC. | $152.65 | 2023 | Itind System, Soltive, Uretero-Reno Videoscope |
| Ferring Pharmaceuticals INC. | $135.02 | 2024-2025 | Adstiladrin |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Marcus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.